F He1, X Lin, F Xie, Y Huang, R Yuan. 1. Department of Hepatobiliary, Sun Yat-sen University Cancer Center, Dongfeng East Road 651, Guangzhou, 510060, Guangdong, China, fengyinghe2014@126.com.
Abstract
OBJECTIVE: To analyze the results after the introduction of enhanced recovery after surgery (ERAS) protocols, a randomized study was performed to compare the outcomes of laparoscopic hepatectomy under ERAS or traditional care. METHODS:Patients undergoing laparoscopic hepatectomy from April 2014 to October 2014 were included and randomly divided into Control group (CG) and ERAS. Primary outcome was quality of life (QoL) and length of hospital stay (LOS). Secondary endpoints were percentage readmission, mortality, duration to first flatus, complications, hospital costs, conversions and blood loss. RESULTS:Thirteen patients withdrew after randomization. Eighty-six patients completed the study, 48 ERAS and 38 CG. Postoperative LOS was significantly reduced in ERAS [6 (4-8) versus 10 (7-15) days, P = 0.04]. First flatus occurred earlier in ERAS than CG [2(1-4) versus 3(2-5) days, P = 0.02]. The average perioperative charges were 9470 ± 1540 in CG and only 7742 ± 1200 in ERAS (P = 0.03), with no differences in readmission rate, blood loss, conversions to open surgery, mortality or surgical complications. The median AUC (area under a curve) of QoL was considerably improved in ERAS (P = 0.04). CONCLUSIONS: This study suggests that ERAS is feasible and safe for laparoscopic hepatectomy.
RCT Entities:
OBJECTIVE: To analyze the results after the introduction of enhanced recovery after surgery (ERAS) protocols, a randomized study was performed to compare the outcomes of laparoscopic hepatectomy under ERAS or traditional care. METHODS:Patients undergoing laparoscopic hepatectomy from April 2014 to October 2014 were included and randomly divided into Control group (CG) and ERAS. Primary outcome was quality of life (QoL) and length of hospital stay (LOS). Secondary endpoints were percentage readmission, mortality, duration to first flatus, complications, hospital costs, conversions and blood loss. RESULTS: Thirteen patients withdrew after randomization. Eighty-six patients completed the study, 48 ERAS and 38 CG. Postoperative LOS was significantly reduced in ERAS [6 (4-8) versus 10 (7-15) days, P = 0.04]. First flatus occurred earlier in ERAS than CG [2(1-4) versus 3(2-5) days, P = 0.02]. The average perioperative charges were 9470 ± 1540 in CG and only 7742 ± 1200 in ERAS (P = 0.03), with no differences in readmission rate, blood loss, conversions to open surgery, mortality or surgical complications. The median AUC (area under a curve) of QoL was considerably improved in ERAS (P = 0.04). CONCLUSIONS: This study suggests that ERAS is feasible and safe for laparoscopic hepatectomy.
Authors: Luigi Camera; Milena Calabrese; Giovanni Sarnelli; Margaret Longobardi; Alba Rocco; Rosario Cuomo; Marco Salvatore Journal: World J Gastroenterol Date: 2011-06-28 Impact factor: 5.742
Authors: Joseph F Buell; Daniel Cherqui; David A Geller; Nicholas O'Rourke; David Iannitti; Ibrahim Dagher; Alan J Koffron; Mark Thomas; Brice Gayet; Ho Seong Han; Go Wakabayashi; Giulio Belli; Hironori Kaneko; Chen-Guo Ker; Olivier Scatton; Alexis Laurent; Eddie K Abdalla; Prosanto Chaudhury; Erik Dutson; Clark Gamblin; Michael D'Angelica; David Nagorney; Giuliano Testa; Daniel Labow; Derrik Manas; Ronnie T Poon; Heidi Nelson; Robert Martin; Bryan Clary; Wright C Pinson; John Martinie; Jean-Nicolas Vauthey; Robert Goldstein; Sasan Roayaie; David Barlet; Joseph Espat; Michael Abecassis; Myrddin Rees; Yuman Fong; Kelly M McMasters; Christoph Broelsch; Ron Busuttil; Jacques Belghiti; Steven Strasberg; Ravi S Chari Journal: Ann Surg Date: 2009-11 Impact factor: 12.969
Authors: Ronald M van Dam; Edgar M Wong-Lun-Hing; Gerard J P van Breukelen; Jan H M B Stoot; Joost R van der Vorst; Marc H A Bemelmans; Steven W M Olde Damink; Kristoffer Lassen; Cornelis H C Dejong Journal: Trials Date: 2012-05-06 Impact factor: 2.279
Authors: Lucas W Thornblade; Yongwoo D Seo; Tracy Kwan; Jane H Cardoso; Eric Pan; Gregory Dembo; Raymond S W Yeung; James O Park Journal: J Gastrointest Surg Date: 2018-02-05 Impact factor: 3.452
Authors: Christoph Kuemmerli; Robert S Fichtinger; Alma Moekotte; Luca A Aldrighetti; Somaiah Aroori; Marc G H Besselink; Mathieu D'Hondt; Rafael Díaz-Nieto; Bjørn Edwin; Mikhail Efanov; Giuseppe M Ettorre; Krishna V Menon; Aali J Sheen; Zahir Soonawalla; Robert Sutcliffe; Roberto I Troisi; Steven A White; Lloyd Brandts; Gerard J P van Breukelen; Jasper Sijberden; Siân A Pugh; Zina Eminton; John N Primrose; Ronald van Dam; Mohammed Abu Hilal Journal: Trials Date: 2022-03-09 Impact factor: 2.279
Authors: Janet Baack Kukreja; Qiuling Shi; Courtney M Chang; Mohamed A Seif; Brandon M Sterling; Ting-Yu Chen; Kelly M Creel; Ashish M Kamat; Colin P Dinney; Neema Navai; Jay B Shah; Xin Shelley Wang Journal: Surg Innov Date: 2018-03-20 Impact factor: 2.058